The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1025
Bid: 0.10
Ask: 0.105
Change: 0.00 (0.00%)
Spread: 0.005 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.1025
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

31 Dec 2020 07:00

RNS Number : 2063K
Versarien PLC
31 December 2020
 

31 December 2020

 

Versarien plc

("Versarien" or the "Company")

Total Voting Rights 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces, that that in conformity with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("FCA"), the Company's issued share capital consists of 189,869,790 Ordinary Shares of 1p each with full voting rights.

The figure of 189,869,790 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Enquiries:

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO

+44 (0)1242 269 122

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Matthew Johnson, Ewan Leggat, Adam Cowl

+44 (0)20 3470 0470

Berenberg (Joint Broker)

Mark Whitmore, Simon Cardron

+44 (0)20 3207 7800

Yellow Jersey (Investor Relations) 

Charles Goodwin

Georgia Colkin

Henry Wilkinson

Versarien@yellowjerseypr.com

+44 (0)20 3004 9512

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRKKKBQBBDBDBN
Date   Source Headline
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:35 pmRNSPrice Monitoring Extension
2nd Nov 20224:35 pmRNSPrice Monitoring Extension
30th Sep 202212:48 pmRNSResult of AGM
28th Sep 20224:41 pmRNSSecond Price Monitoring Extn
28th Sep 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSBiaBrazil to utilise Graphene-Wear Technology
24th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSVerified Graphene Producer Re-certification
27th Jun 20227:00 amRNSLaunch of New Superparamagnetic Material
12th May 20227:00 amRNSInterim Results
10th May 20227:00 amRNSUmbro to Utilise Versarien’s Graphene-Wear Tech
3rd May 20227:00 amRNSNotice of Results and Investor Presentation
25th Apr 20223:25 pmRNSHolding(s) in Company
9th Mar 20227:00 amRNSLaunch of Lunar 3D printed lifestyle pods
24th Feb 20227:00 amRNSChange of Auditors and Accounting Reference Date
22nd Feb 20227:00 amRNSFlux Footwear to launch graphene enhanced shoe
20th Jan 20227:00 amRNSInvestor Event
4th Jan 20227:00 amRNSConfirmation of Board Change
24th Dec 20217:00 amRNSHolding(s) in Company
10th Dec 20217:00 amRNSInvestor Presentation
6th Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSNotice of Results and Investor Presentation
17th Nov 20212:27 pmRNSHolding(s) in Company
16th Nov 202112:31 pmRNSSuperdry partners with Versarien
11th Nov 20217:00 amRNSInvestor Presentation
1st Nov 20217:00 amRNSConsortium wins Department for Transport backing
29th Oct 20211:41 pmRNSResponse to Media Speculation
29th Oct 20217:00 amRNSInvestor Presentation
13th Oct 20217:00 amRNSAppointment of Non-executive Chairman
23rd Sep 20212:08 pmRNSResult of AGM
2nd Sep 202111:01 amRNSChange of Registered Address
27th Aug 20211:54 pmRNSNotice of AGM and Posting of Annual Report
11th Aug 20219:53 amRNSHolding(s) in Company
5th Aug 20217:00 amRNSPreliminary Results
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20217:00 amRNS£1.93m strategic investment by Graphene Lab
26th Feb 202110:16 amRNSInnovate UK Loan
9th Feb 20217:00 amRNSGraphene Enhanced Mask Update
22nd Jan 202111:05 amRNSDirector/PDMR Shareholding
21st Jan 20217:00 amRNSInterim Results
7th Jan 20217:00 amRNSAppointment of Chief Technology Officer
31st Dec 20207:00 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSHolding(s) in Company
23rd Dec 202012:31 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSAcquisition, Subscription & Sharing Agreement
24th Nov 20207:00 amRNS£1.95 million Development Agreement
23rd Nov 20204:39 pmRNSInterim Results Reporting Extension
18th Nov 20207:00 amRNSSARS-CoV-2 Inhibition by Graphene / Metal Oxides
21st Oct 202012:00 pmRNSResult of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.